Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Complete Response
100%
Isolated Limb Perfusion
100%
In-transit Melanoma
100%
Iliac
54%
In-field Recurrence
45%
Lymph Node
27%
Hazard Ratio
18%
Clinical Parameters
18%
Lymph Node Status
18%
Free Survival
18%
Melphalan
18%
Pathological Parameters
18%
95% Confidence Interval
18%
Melanoma
9%
Cox Model
9%
Interferon-α (IFN-α)
9%
Tumor Necrosis Factor-α
9%
Cox Proportional Hazards Model
9%
Advanced Melanoma
9%
Univariate Analysis
9%
Lower Extremity
9%
Improved Outcomes
9%
Log-rank Test
9%
Prior Treatment
9%
Median Time
9%
Risk of Death
9%
Overall Survival
9%
Hyperthermia
9%
Systemic Therapy
9%
Initial Diagnosis
9%
Female Sex
9%
Improved Survival
9%
Adjuvant Systemic Therapy
9%
Two-variable
9%
Complete Response Rate
9%
Large Lesions
9%
Lesion Size
9%
Out-of-field
9%
In-transit
9%
Limb Volume
9%
Medicine and Dentistry
Limb Perfusion
100%
Melanoma
100%
Lymph Node
45%
Recurrent Disease
27%
Proportional Hazards Model
18%
Hazard Ratio
18%
Recurrence Free Survival
18%
Melphalan
18%
Overall Survival
9%
Interferon
9%
Adjuvant Therapy
9%
Univariate Analysis
9%
Log Rank Test
9%
Limb
9%
Systemic Therapy
9%
Tumor Necrosis Factor
9%
Diseases
9%
Nursing and Health Professions
Melanoma
100%
Limb Perfusion
100%
Recurrent Disease
27%
Confidence Interval
18%
Proportional Hazards Model
18%
Hazard Ratio
18%
Recurrence Free Survival
18%
Melphalan
18%
Univariate Analysis
9%
Systemic Therapy
9%
Tumor Necrosis Factor
9%
Adjuvant Therapy
9%
Log Rank Test
9%
Overall Survival
9%
Interferon
9%
Diseases
9%